CellCept (Mycophenolate Mofetil) ( DrugBank: Mycophenolate mofetil, Mycophenolate )


2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
42結節性多発動脈炎5
43顕微鏡的多発血管炎1

42. 結節性多発動脈炎


臨床試験数 : 15 薬物数 : 26 - (DrugBank : 16) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 105
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-004668-71-ES
(EUCTR)
13/10/201605/08/2016A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 19.0;Level: LLT;Classification code 10036026;Term: Polyarteritis nodosa of childhood;System Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
INN or Proposed INN: CYCLOPHOSPHAMIDE
University College LondonNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden
2EUCTR2013-004668-71-IT
(EUCTR)
01/08/201614/07/2015An Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN An Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 19.0;Level: LLT;Classification code 10036026;Term: Polyarteritis nodosa of childhood;System Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
University College LondonNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden
3EUCTR2013-004668-71-GB
(EUCTR)
25/09/201425/09/2014A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 17.0;Level: LLT;Classification code 10036026;Term: Polyarteritis nodosa of childhood;System Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
University College LondonNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Croatia;Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Germany;Netherlands;Sweden
4EUCTR2013-004668-71-PT
(EUCTR)
16/02/2016A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 18.1;Level: LLT;Classification code 10036026;Term: Polyarteritis nodosa of childhood;System Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
INN or Proposed INN: CYCLOPHOSPHAMIDE
University College LondonNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden
5EUCTR2013-004668-71-BE
(EUCTR)
12/04/2017A study of treatment for polyarteritis nodosa in childrenAn Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa - MYPAN Childhood systemic polyarteritis nodosa (PAN)
MedDRA version: 19.1;Level: LLT;Classification code 10036026;Term: Polyarteritis nodosa of childhood;System Organ Class: 100000004866;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: CellCept (Mycophenolate Mofetil)
Product Name: CellCept (Mycophenolate Mofetil)
INN or Proposed INN: Mycophenolate mofetil
Trade Name: Cyclophosphamide
Product Name: Cyclophosphamide
INN or Proposed INN: CYCLOPHOSPHAMIDE
INN or Proposed INN: CYCLOPHOSPHAMIDE
University College LondonNULLNot RecruitingFemale: yes
Male: yes
40Phase 3Portugal;Slovenia;Greece;Spain;Turkey;United Kingdom;Italy;Czech Republic;Belgium;Poland;Croatia;Germany;Netherlands;Sweden

43. 顕微鏡的多発血管炎


臨床試験数 : 88 薬物数 : 81 - (DrugBank : 21) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 90
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00405860
(ClinicalTrials.gov)
December 200229/11/2006CellCept in p-ANCA VasculitisA Pilot Study of Mycophenolate Mofetil (MMF) in Patients With p-ANCA Microscopic Polyangiitis and Mild to Moderate Renal Dysfunction.MPO-ANCA Vasculitis;Microscopic PolyangiitisDrug: CellCept (mycophenolate mofetil)Mayo ClinicRoche Pharma AGCompleted18 YearsN/ABoth18Phase 1United States